Andreas is a serial entrepreneur building deep tech startups originating in Asia, Europe and the US. After selling his last company Proteona to Singleron Biotechnologies, he is heading their global business development, applying single cell technologies to precision medicine. Andreas is involved in multiple start up companies as board member, mentor and shareholder often with a focus on multi-omics and data-driven technologies for cell and gene therapies as well as diagnostics. Andreas is an immunologist by training from Berkeley and one of the early entrepreneurs of the SMART Singapore MIT Alliance of Research and Technology.